The Claim
Apigenin at a concentration of 10 μM suppresses the secretion of IL-6, IL-8, GROA, and CXCL10 by senescent human fibroblasts induced by ionizing radiation, oncogenic RAS, or replicative exhaustion, resulting in a reduction of the inflammatory microenvironment that promotes cancer cell aggressiveness.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Apigenin at 10 μM reduces the release of specific inflammatory signals from aged human skin cells damaged by radiation, cancer genes, or natural aging, which lowers the surrounding inflammation that makes cancer cells more aggressive.
See the scientific wording
Apigenin at a concentration of 10 μM suppresses the secretion of multiple pro-inflammatory SASP factors—including IL-6, IL-8, GROA, and CXCL10—by senescent human fibroblasts induced by ionizing radiation, oncogenic RAS, or replicative exhaustion, thereby reducing the inflammatory microenvironment that promotes cancer cell aggressiveness.
Apigenin blocks a specific inflammatory signal chain in aged cells, preventing them from releasing chemicals that make nearby cancer cells more aggressive. This stops the aged cells from sending out distress signals that fuel cancer growth and spread.
What the research says
1 studyApigenin, a natural compound in some plants, was shown in the lab to calm down harmful inflammatory signals from old, damaged human cells. This calming effect made nearby breast cancer cells less aggressive and less likely to spread.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.